Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Renovaro Inc. - Common Stock
(NQ:
RENB
)
1.530
-0.170 (-10.00%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,044,301
Open
1.790
Bid (Size)
1.480 (30)
Ask (Size)
1.530 (11)
Prev. Close
1.700
Today's Range
1.500 - 2.100
52wk Range
0.6601 - 5.250
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Trailblazing AI Driven Early Cancer Diagnostics and Therapeutics for Detection with Nvidia Super Computing Power; Acquiring 100% Ownership of Cyclomics; Renovaro Inc. (Nasdaq: RENB)
April 25, 2024
Via
Get News
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
April 24, 2024
From
Renovaro Inc
Via
GlobeNewswire
Performance
YTD
-52.04%
-52.04%
1 Month
-42.26%
-42.26%
3 Month
-64.91%
-64.91%
6 Month
-44.96%
-44.96%
1 Year
+103.46%
+103.46%
More News
Read More
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient
April 18, 2024
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
March 14, 2024
Via
Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Chemours, Trupanion, and Renovaro and Encourages Investors to Contact the Firm
March 04, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
February 27, 2024
Via
NewMediaWire
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
February 27, 2024
Via
TheNewswire.com
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 04, 2024
Via
Benzinga
ROSEN, A TOP RANKED LAW FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB
February 24, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Red Flag Alert: 3 Stocks That Hindenburg Research Is Shorting Now
February 22, 2024
Via
InvestorPlace
RENOVARO ALERT: Bragar Eagel & Squire, P.C. is Investigating Renovaro Biosciences Inc. on Behalf of Renovaro Stockholders and Encourages Investors to Contact the Firm
February 20, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
February 20, 2024
Via
NewMediaWire
ROSEN, A LEADING LAW FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
February 20, 2024
Via
TheNewswire.com
RENB SHAREHOLDER ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB
February 19, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Cutting Edge Blood Genetic Testing Using Nvidia AI Chips Emerging from Acquisition of Dutch Based Cyclomics; Aim to Disrupt Cancer Diagnosis and Treatment: Renovaro Biosciences Inc. (Nasdaq: RENB)
February 16, 2024
Via
Get News
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace
February 15, 2024
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
Hit With Short Seller Report, Renovaro Biosciences Comments On Hindenburg's Opinion Piece
February 14, 2024
Via
Benzinga
Statement of Renovaro Inc
February 14, 2024
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
BioMedNewsBreaks – Renovaro Inc. (NASDAQ: RENB) Fusing AI and Biotech to Accelerate Personalized Medicine, GEDiCube, Cyclomics Enter LOI to ‘Change the Field’
February 13, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
ROSEN, A LEADING NATIONAL FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB
February 13, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 13, 2024
Via
Benzinga
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 13, 2024
Via
Benzinga
Renovaro Biosciences Faces Turmoil After Hindenburg Report Accusing Questionable Merger And Governance, Stock Crashes
February 13, 2024
Via
Benzinga
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace
February 13, 2024
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine
February 13, 2024
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.